'''RIGVIR''' is a [[virotherapy]] approved by the [[State Agency of Medicines of Latvia]].<ref name="Chumakov">For an freely accessible English version see page 642 of {{cite journal| author=Chumakov PM, Morozova VV, Babkin IV, Baikov IK, Netesov SV, Tikunova NV| title=Oncolytic enteroviruses | journal=Molecular Biology | year= 2012 | volume= 46 | issue= 5 | pages= 639-50 | pmid= | doi=10.1134/S0026893312050032 | pmc= |url=http://www.virotherapy.eu/publications/preclinical/oncolytic-enteroviruses-2012.pdf}}<br/>
For the original version in Russian see {{cite journal| author=Chumakov PM, Morozova VV, Babkin IV, BaÄ­kov IK, Netesov SV, Tikunova NV| title=[Oncolytic enteroviruses] (Russian). | journal=Molekulyarnaya Biologiya | year= 2012 | volume= 46 | issue= 5 | pages= 712-25 | pmid=23156670 | doi= | pmc= }} </ref> It was developed in the 1960s and 1970s by Aina Muceniece (1924-2010) and patented in 2002.<ref>{{cite web|title=Inventions and Inventors of Latvia|url=http://izgudrojumi.lza.lv/izg_en.php?id=68|accessdate=8 April 2013}}</ref> 

==See also==
*[[Oncolytic virus]]

==References==
{{reflist}}

==External links==
*[http://www.viroterapija.lv/latvian_virotherapy_center_en.html Latvian Virotherapy Center] 

[[Category:Experimental cancer treatments]]
[[Category:Research in Latvia]]
[[Category:Immunomodulating drugs]]
[[Category:Virotherapy]]